January 23, 2009 / 10:37 AM / 10 years ago

FACTBOX-Largest M&A deals in pharma sector

 Jan 23 (Reuters) - Pfizer Inc (PFE.N), the world’s largest drugmaker by revenue, is in talks to acquire rival Wyeth WYE.N in a deal that could be valued at more than $60 billion, the Wall Street Journal reported on its website.
 Following is a list of the top ten M&A deals in the pharma sector: ACQUIROR              TARGET                  VALUE    COMPLETED
                                         ($ billion) ———————————————————————————————— Pfizer Inc            Warner-Lambert Co       88.77   19/06/2000 Glaxo Wellcome PLC    SmithKline Beecham PLC  78.77   27/12/2000 Sanofi-Synthelabo SA  Aventis SA              65.65   20/08/2004 Pfizer Inc            Pharmacia Corp          60.7    15/04/2003 Roche Holding AG      Genentech Inc           43.65    * ZENECA Group PLC      Astra AB                31.77   06/04/1999 Rhone-Poulenc SA      Hoechst AG              28.35   15/12/1999 Sandoz AG             Ciba-Geigy AG           28.22   17/12/1996 Novartis AG           Alcon Inc               27.73   ** Monsanto Co           Pharmacia & Upjohn Inc  26.77   31/03/2000   *  Announced July 21, 2008.   ** Announced April 7, 2008.   Source: Thomson Reuters;
 (Compiled by Jijo Jacob; Editing by David Cowell)             

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below